KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »SEARCH RESULT
Total Matching Records found : 41
Tuberculosis cases rise for the first time in years, says WHO
-AP/ The Hindu The World Health Organization says the number of people infected with tuberculosis, including the kind resistant to drugs, rose globally for the first time in years in 2021 The number of people infected with tuberculosis, including the kind resistant to drugs, rose globally for the first time in years, according to a report issued Thursday by the World Health Organization. The U.N. health agency said more than 10 million people...
More »Tuberculosis deaths and disease increase during the COVID-19 pandemic
-Press release by World Health Organisation dated 27 October, 2022 An estimated 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million people died from TB (including 187 000 among HIV positive people), according to the World Health Organization’s 2022 Global TB report. The burden of drug-resistant TB (DR-TB) also increased by 3% between 2020 and 2021, with 450 000 new cases...
More »How dosage of fever drugs has again highlighted nexus of pharma firms, doctors -Vivek Mishra
-Down to Earth No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows If you had to take paracetamol 650 milligrams instead of paracetamol 500 mg three times a day during the COVID-19 pandemic, you may be familiar with the drug called Dolo-650. The drug is prescribed for reducing fever and pain, but the medicine possibly reached you thanks to its manufacturer’s market strategy. A petition...
More »Expired pill: Editorial on new drugs and cosmetics bill
-The Telegraph There is no mention of compliance with ‘good manufacturing practices’ or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the...
More »
